SUNIL BHONSLE

CIK 1180755 · President and CEO · last filed 2019-04-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

30

Lifetime Open-Market Net

$303.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TITAN PHARMACEUTICALS INC (TTNP) Delisted President and CEO 490,262 $4.61 $2.26M $236.3K 11 2019-04-03
TITAN PHARMACEUTICALS INC (TTP) Delisted Executive VP and COO 461,394 $47.61 $21.97M $67.5K 7 2008-10-22

Recent Filings · Page 2 of 3

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-12-16 TITAN PHARMACEUTICALS INC (TTNP) Delisted Grant (A) $0 EDGAR
2015-10-01 Buy (P) +700 $2.8K
2015-09-29 Buy (P) +910 $3.3K
2015-09-16 Buy (P) +10,000 $7.0K
2015-08-26 Buy (P) +50,000 $34.8K
2015-03-18 Grant (A) $0
2014-10-14 Buy (P) +216,000 $102.7K
2014-02-14 Grant (A) +100,000 $66.0K
2013-06-19 Buy (P) +50,000 $22.8K
2013-02-27 Exer (M) +50,000 $75.0K
Showing 1120 of 30
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.